190
Participants
Start Date
May 31, 2008
Primary Completion Date
April 30, 2013
Study Completion Date
April 30, 2013
Placebo
Zoledronic acid
Novartis Investigative Site, Budapest
Novartis Investigative Site, Budapest
Novartis Investigative Site, Budapest
Novartis Investigative Site, St Leonards
Novartis Investigative Site, Hamar
Novartis Investigative Site, Leuven
Novartis Investigative Site, Bern
Novartis Investigative Site, Parkville
Novartis Investigative Site, Geelong
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Bergen
Novartis Investigative Site, Zurich
Novartis Investigative Site, Balatonfüred
Novartis Investigative Site, Ghent
Novartis Investigative Site, Győr
Novartis Investigative Site, Berlin
Novartis Investigative Site, Pittsburgh
Novartis Investigative Site, Arenzano
Novartis Investigative Site, Richmond
Novartis Investigative Site, Hanover
Novartis Investigative Site, Gainesville
Novartis Investigative Site, Padua
Novartis Investigative Site, Braunfels
Novartis Investigative Site, Valeggio sul Mincio
Novartis Investigative Site, Magdeburg
Novartis Investigative Site, Khonkaen
Novartis Investigative Site, Indiamapolis
Novartis Investigative Site, Chaingmai
Novartis Investigative Site, Siena
Novartis Investigative Site, Fargo
Novartis Investigative Site, Lyon
Novartis Investigative Site, Lakewood
Novartis Investigative Site, München
Novartis Investigative Site, Albuquerque
Novartis Investigative Site, Seattle
Novartis Investigative Site, San Diego
Novartis Investigative Site, Bangor
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, Caba
Novartis Investigative Site, Quilmes
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Montreal
Novartis Investigative Site, Sainte-Foy
Novartis Investigative Site, Barranquilla
Novartis Investigative Site, Bogotá
Novartis Investigative Site, Medellín
Novartis Investigative Site, Hong Kong
Novartis Investigative Site, Grafton
Novartis Investigative Site, Helsinki
Novartis Investigative Site, Oslo
Novartis Investigative Site, Oslo
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Bialystok
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Gothenburg
Novartis Investigative Site, Stockholm
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY